XML 17 R7.htm IDEA: XBRL DOCUMENT v3.23.3
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Cash flows provided by operating activities:    
Net income (loss) $ (9,640) $ (251,580)
Adjustments to reconcile net loss to net cash provided by operating activities:    
Depreciation, amortization and accretion 65,688 72,151
Stock-based compensation expense 10,638 4,433
Noncash consideration, net, associated with wholesale capacity contract (2,216) 0
Reduction in value of long-lived assets and inventory 35 175,079
Noncash interest and accretion expense 12,304 23,788
Unrealized foreign currency loss 131 13,399
Write off of debt discount and deferred financing costs upon extinguishment of debt 10,194 0
Noncash expenses associated with SSA, net of amortization 892 0
Other, net (477) 738
Changes in operating assets and liabilities:    
Accounts receivable 2,082 (952)
Inventory (2,029) (1,295)
Prepaid expenses and other current assets (145) 1,788
Other assets (515) 352
Accounts payable and accrued expenses (5,435) (10,272)
Payables to affiliates (173) (303)
Other non-current liabilities 45 (2,602)
Deferred revenue (12,823) 6,981
Net cash provided by operating activities 68,556 31,705
Cash flows used in investing activities:    
Payments under the satellite procurement agreement (110,215) 0
Other network upgrades to support the Service Agreements (18,085) (18,604)
Payments of capitalized interest (8,810) 0
Network upgrades to support product development (4,960) (5,839)
Purchase of intangible assets (315) (863)
Net cash used in investing activities (142,385) (25,306)
Cash flows provided by (used in) financing activities:    
Proceeds from 2023 Funding Agreement 87,730 0
Principal payment of 2021 Funding Agreement (6,250) 0
Dividends paid on Series A Preferred Stock (9,269) 0
Payments for debt issuance costs (8,556) 0
Proceeds from issuance of common stock and exercise of options 528 455
Net cash provided by (used in) financing activities 105,902 (5,886)
Effect of exchange rate changes on cash, cash equivalents and restricted cash (19) (68)
Net increase in cash, cash equivalents and restricted cash 32,054 445
Cash, cash equivalents and restricted cash, beginning of period 32,082 14,304
Cash, cash equivalents and restricted cash, end of period 64,136 14,749
Reconciliation of cash and cash equivalents    
Cash and cash equivalents 64,136  
Total cash and cash equivalents cash shown in the statement of cash flows 64,136 14,749
Supplemental disclosure of cash flow information:    
Cash paid for interest 13,512 0
Supplemental disclosure of non-cash financing and investing activities:    
Increase in capitalized accrued interest for network upgrades 3,547 8,615
Capitalized accretion of debt discount and amortization of prepaid financing costs 3,620 1,305
Satellite construction assets acquired through vendor financing arrangement 0 69,896
Re-characterization of 2021 Funding Agreement to debt 87,950 0
Lease Agreement    
Supplemental disclosure of non-cash financing and investing activities:    
Fair value of common stock issued 58,534 0
SSA    
Supplemental disclosure of non-cash financing and investing activities:    
Fair value of common stock issued 11,887 0
2019 Facility Agreement    
Cash flows provided by (used in) financing activities:    
Principal and interest payments of the 2019 Facility Agreement (148,281) (6,341)
2023 13% Notes    
Cash flows provided by (used in) financing activities:    
Proceeds from 2023 13% Notes $ 190,000 $ 0